#Latest news with #biologicaldataForbes2 days agoBusinessForbesHow AI Is Fixing The 90% Drug Failure RateChris Gibson, Cofounder and CEO of Recursion, lays out how his company is building the biological data, and layering on AI, to assist in the development of new, effective therapeutics.
Forbes2 days agoBusinessForbesHow AI Is Fixing The 90% Drug Failure RateChris Gibson, Cofounder and CEO of Recursion, lays out how his company is building the biological data, and layering on AI, to assist in the development of new, effective therapeutics.